Comments on: FDA approves Novartis’ Piqray as the first drug targeting PIK3CA mutation

Comments on: FDA approves Novartis’ Piqray as the first drug targeting PIK3CA mutation /news/fda-novartis-piqray-pik3ca-mutation/ The leading site for news and procurement in the pharmaceutical industry Tue, 28 May 2019 13:16:12 +0000 hourly 1 https://wordpress.org/?v=6.6.2